Results from the trial, presented at the fourth International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, demonstrate that the drug, INCB9471, provided a significant decline in
However, earnings per share for the period dropped 29% from $1.08 to $1.53. The company said that key drugs such as Cymbalta and Alimta had boosted sales in
The study was designed to determine the effects of vaccination with HspE7 in women with high-grade cervical intraepithelial neoplasia (CIN II/III), a precursor to cervical cancer. The results
As of July 20, 2007, the company closed recruitment at 638 patients. The patient population is made up of 228 Canadian patients, 294 patients from Germany and 116
The study is an ongoing phase III, open-label clinical trial in the US and Europe. Truvada is a fixed-dose once-daily tablet containing Gilead’s Viread and Emtriva. At study
Under the agreement, Depomed has granted Watson a co-exclusive right to promote ProQuin XR for the urology and long-term care specialties in the US and its possessions, including
Arius said that it expects to file an IND application and begin human clinical trials in 2008. The biotechnology company is developing the compound for the treatment of
The first part of the trial is a single arm, open-label dose titration to evaluate the effective individual dose for significant pain relief with fentanyl Taifun in the
Netherlands-based Qiagen said that preliminary tabulations suggest that the number of shares tendered constitute well over 90% of Digene’s stock, meaning that the company can go on to
Veralipride is marketed under the trade names of Agreal or Agradil in Belgium, France, Italy, Luxembourg and Portugal by Sanofi-Aventis. The EMEA’s Committee for Medicinal Products for Human
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.